John McGrane
John McGrane publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology, on topics such as Renal cell carcinoma treatment, Endometrial and Cervical Cancer Treatments and Prostate Cancer Treatment and Research.
- World rank
- #5,226,593 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #310,296 of 367,258
- Works
- 63
- Citations
- 471
- Citations per work
- 7.5
What does John McGrane research?
John McGrane's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4063.6%
- Medicine4063.6%
- Everything else1828.9%
- Life Sciences57.5%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Oncology15% of their works
- 3Obstetrics and Gynecology9% of their works
- 4Cancer Research8% of their works
- 5Surgery6% of their works
- 6Radiology, Nuclear Medicine and Imaging6% of their works
Research topics
- Renal cell carcinoma treatment
- Endometrial and Cervical Cancer Treatments
- Prostate Cancer Treatment and Research
- Cancer Genomics and Diagnostics
- Radiopharmaceutical Chemistry and Applications
- Ovarian cancer diagnosis and treatment
- Economic and Financial Impacts of Cancer
- Cancer Immunotherapy and Biomarkers
Which keywords describe John McGrane's research?
The keywords of their largest research topics: Genetic Mutations, Immunotherapy, Metastatic, Renal Cell Carcinoma, Biomarkers, Clinical Trials, Cervical Cancer and Endometrial Carcinoma.
- Immune Checkpoint Blockade
- PET Imaging
- Mutational Signatures
- Financial Toxicity
- Cancer Genomics
- Androgen Receptor
- Endometrial Carcinoma
- Clinical Trials
- Renal Cell Carcinoma
- Immunotherapy
- Genetic Mutations
- Metastatic
- Biomarkers
- Cervical Cancer
- Targeted Therapy
- Prostate Cancer
- Cost of Care
- Genomic Analysis
- Ovarian Cancer
- Radiopharmaceuticals
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Genetic Mutations262 topics
- Immunotherapy262 topics
- Metastatic171 topic
- Renal Cell Carcinoma171 topic
- Biomarkers152 topics
- Clinical Trials152 topics
- Cervical Cancer141 topic
- Endometrial Carcinoma141 topic
- Targeted Therapy122 topics
- Androgen Receptor91 topic
- Prostate Cancer91 topic
- Cancer Genomics61 topic
- Cost of Care61 topic
- Financial Toxicity61 topic
- Genomic Analysis61 topic
- Mutational Signatures61 topic
- Ovarian Cancer61 topic
- PET Imaging61 topic
- Radiopharmaceuticals61 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
Where does John McGrane work?
John McGrane's main affiliation in the publication record is Royal Cornwall Hospital Trust, United Kingdom.
How many publications and citations does John McGrane have?
OpenAlex counts 63 works and 471 citations for John McGrane, an h-index of 10, ranking #5,226,593 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named John McGrane
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John McGrane. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.